OTC MARKETS · BSEM

-4.55% · -$0.2000 · Vol 129.7K

After hours · updated 18:22:28 ET

Biostem Technologies Inc

Pharmaceuticals

$4.20

Card

Relationship Map

Follow $BSEM

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $BSEM by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measured

Stale score · Mon Sep 21 · completed session · 25h old · Scheduled each trading day · Markets closed · resumes Wed 9:30 ET · BSEM

Methodology

Tue Sep 22 snapshot unavailable for BSEM. Cause unavailable.

BSEM

Biostem Technologies Inc

Stale score · Mon Sep 21 · completed session · 25h old · Scheduled each trading day · Markets closed · resumes Wed 9:30 ET

60/100

Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

60/ 100

Veridion Score

Upper range · MEDIUM confidence · 6 of 6 factors measured

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: MEDIUM · 6 of 6 factors measured · Stale score · Mon Sep 21 · completed session · 25h old · Scheduled each trading day · Markets closed · resumes Wed 9:30 ET

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is BSEM moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move BSEM next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Sep 21
Score
Score moved +5
55/Middle range -> 60/Upper range
Veridion score historySource

About Biostem Technologies Inc

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Listed since

2008

Employees

Country

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$4.36

Day high

$4.61

Day low

$3.95

Previous close

$4.40

52W high

$8.20

-48.78% from high

52W low

$3.00

23% of range

Market cap

$78.9M

EPS

$-1.2028

Beta

0.54

Shares out

17.9M

Volume

129.7K

0.83× rel vol

Avg volume

157K

VWAP

$4.24

Price history computed in-house

+4.74%

+18.64%

+12.30%

-16.67%

YTD

+10.24%

SMA 50 $3.74 · above

SMA 200 $4.45 · below

52W position 23%

BSEM overview

Veridion Score

Registered · 2026-09-21

6 of 6 factors measured

Latest receipt rows

No recent disclosure on file.

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around BSEM.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

BSEM insider activity

Biostem Technologies Inc

Score

Not evaluated

Pressure

Not evaluated

Filings

Buys / sells

0 / 0

Net value

Not evaluated

Insiders

Cluster

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

Form 4 evidence state

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in BSEM

Congress tracker Open ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for BSEM in the cached public ledger.

Federal contracts

BSEM contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for BSEM in this window.

Lobbying spend

BSEM lobbying filings, year to date.

Registered lobbying filings matched to Biostem Technologies Inc.

Not disclosed

Refresh interval: 12hSource: LDA disclosure filings

No lobbying filings on file for BSEM in this window.

Analyst ratings

Sovereign unlock shows live analyst consensus for BSEM.

Options

Sovereign unlock shows live options positioning for BSEM.

Related tickers

Cross-references from this score page.

Apprentice · 1 rail

Similar headline score

Nearest public composite scores. Factor similarity requires Sovereign.

Methodology

No related ticker met the data requirements for this rail.

Follow $BSEM

Why is BSEM moving today?

What can move BSEM next.

BSEM overview

Related filings and maps

BSEM insider activity

BSEM contract awards, year to date.

BSEM lobbying filings, year to date.

Cross-references from this score page.

What can move BSEM next.

BSEM insider activity

Cross-references from this score page.